ALD-201, bone marrow-derived cells for coronary artery disease
ALD products are bone marrow-derived cells selected by their high expression of aldehyde dehydrogenase (ALDH). ALD-201 cells are used for treatment of ischemic heart failure. The treatment improves blood flow and clinical status and reduces ischemia.
Read More
Product Information for
ALD-201, bone marrow-derived cells for coronary artery disease
Links related to the product - may include a range of information sources (e.g., press releases, websites, patents) related to the specific cell therapy application.
Access to this data is limited to
LifeMap Discovery Registered users onlySign in for full access
Access to this data is limited to
LifeMap Discovery Registered users onlySign in for full access
Access to this data is limited to
LifeMap Discovery Registered users onlySign in for full access